Omnicell Inc (OMCL) - Total Assets
Based on the latest financial reports, Omnicell Inc (OMCL) holds total assets worth $1.97 Billion USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Omnicell Inc - Total Assets Trend (2000–2025)
This chart illustrates how Omnicell Inc's total assets have evolved over time, based on quarterly financial data. Also see how much is Omnicell Inc worth for the company's overall valuation and market capitalisation.
Omnicell Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Omnicell Inc's total assets of $1.97 Billion consist of 34.4% current assets and 65.6% non-current assets. Review debt load of Omnicell Inc to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 10.0% |
| Accounts Receivable | $216.86 Million | 11.0% |
| Inventory | $100.91 Million | 5.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $170.10 Million | 8.6% |
| Goodwill | $737.95 Million | 37.4% |
Asset Composition Trend (2000–2025)
This chart illustrates how Omnicell Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See current stock price of Omnicell Inc for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Omnicell Inc's current assets represent 34.4% of total assets in 2025, a decrease from 82.3% in 2000.
- Cash Position: Cash and equivalents constituted 10.0% of total assets in 2025, down from 22.1% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 45.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is goodwill at 37.4% of total assets.
Omnicell Inc Competitors by Total Assets
Key competitors of Omnicell Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Heren Health Co Ltd
SHE:300550
|
China | CN¥1.41 Billion |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$17.99 Million |
|
Trivarx Ltd
AU:TRI
|
Australia | AU$16.53 Million |
|
Opyl Ltd
AU:OPL
|
Australia | AU$384.82K |
|
Oakridge International Ltd
AU:OAK
|
Australia | AU$2.12 Million |
|
Carespan Health Inc
V:CSPN
|
Canada | CA$116.81K |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$610.14 Million |
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$92.19 Million |
Omnicell Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.43 | 1.37 | 3.09 |
| Quick Ratio | 1.22 | 1.22 | 2.76 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $203.46 Million | $219.81 Million | $611.73 Million |
Omnicell Inc - Advanced Valuation Insights
This section examines the relationship between Omnicell Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.52 |
| Latest Market Cap to Assets Ratio | 0.77 |
| Asset Growth Rate (YoY) | -6.9% |
| Total Assets | $1.97 Billion |
| Market Capitalization | $1.53 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Omnicell Inc's assets below their book value (0.77x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Omnicell Inc's assets decreased by 6.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Omnicell Inc (2000–2025)
The table below shows the annual total assets of Omnicell Inc from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $1.97 Billion | -6.89% |
| 2024-12-31 | $2.12 Billion | -4.76% |
| 2023-12-31 | $2.23 Billion | +0.73% |
| 2022-12-31 | $2.21 Billion | +3.19% |
| 2021-12-31 | $2.14 Billion | +17.43% |
| 2020-12-31 | $1.82 Billion | +47.04% |
| 2019-12-31 | $1.24 Billion | +14.76% |
| 2018-12-31 | $1.08 Billion | +10.30% |
| 2017-12-31 | $980.30 Million | +4.83% |
| 2016-12-31 | $935.10 Million | +61.57% |
| 2015-12-31 | $578.75 Million | +3.31% |
| 2014-12-31 | $560.21 Million | +13.75% |
| 2013-12-31 | $492.50 Million | +10.99% |
| 2012-12-31 | $443.73 Million | +22.59% |
| 2011-12-31 | $361.97 Million | +5.44% |
| 2010-12-31 | $343.30 Million | +6.84% |
| 2009-12-31 | $321.34 Million | +3.96% |
| 2008-12-31 | $309.09 Million | -5.89% |
| 2007-12-31 | $328.42 Million | +112.39% |
| 2006-12-31 | $154.63 Million | +53.97% |
| 2005-12-31 | $100.43 Million | +0.94% |
| 2004-12-31 | $99.49 Million | +17.79% |
| 2003-12-31 | $84.47 Million | +28.87% |
| 2002-12-31 | $65.54 Million | -9.11% |
| 2001-12-31 | $72.11 Million | +64.25% |
| 2000-12-31 | $43.91 Million | -- |
About Omnicell Inc
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for th… Read more